


The objective of the fund is to achieve absolute returns through targeted investment strategies independent of United Kingdom market conditions or indices.
| Name | % Net Assets |
|---|---|
| Elementis | 5.6% |
| Glaxosmithkline Ord Gbp0.25 | 4.4% |
| Omega Insurance Hl Com Stk Usd0.10 | 4.4% |
| Filtrona Ord Gbp0.25 | 4.3% |
| Booker Group Ord Gbp0.01 | 3.9% |
| Xaar Ord Gbp0.10 | 3.7% |
| Johnson Service Gp Ord Gbp0.10 | 3.6% |
| Hansteen Hldgs Ord Gbp0.10 | 3.3% |
| Menzies(John) Ord Gbp0.25 | 3.3% |
| Scapa Group Ord Gbp0.05 | 3.0% |
| Key | % Net Assets |
|---|---|
| 5.6% | |
| 4.4% | |
| 4.4% | |
| 4.3% | |
| 81.3% |
| Date | 30-May-2025 |
|---|---|
| NAV | 225.10p |
| Currency | GBP |
| Change | 0.20p |
| % | 0.09% |
| YTD change | -0.80p |
| YTD % | -0.35% |
| Fund Inception | 07/09/2009 |
|---|---|
| Fund Manager | n/a |
| Minimum Investment | |
|---|---|
| Initial | £500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research